CRUSIA 2 000 IU (20 MG)/0.2 ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE - patient leaflet, side effects, dosage

Package leaflet: Information for the user

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.

Crusia 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringe

Crusia 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe

Crusia 6,000 IU (60 mg)/0.6 mL solution for injection in pre-filled syringe

Crusia 8,000 IU (80 mg)/0.8 mL solution for injection in pre-filled syringe

Crusia 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringe

enoxaparin sodium

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

• – Keep this leaflet. You may need to read it again.

• – If you have any further questions, ask your doctor, pharmacist or nurse.

• – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

• – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

• 1. What Crusia is and what it is used for

• 2. What you need to know before you use Crusia

• 3. How to use Crusia

• 4. Possible side effects

• 5. How to store Crusia

• 6. Contents of the pack and other information

1. what crusia is and what it is used for

Crusia contains the active substance called enoxaparin sodium that is a low molecular weight heparin (LMWH).

Crusia works in two ways.

• 1) Stopping existing blood clots from getting any bigger. This helps your body to break them down and stops them from causing you harm

• 2) Stopping blood clots from forming in your blood.

Crusia can be used to:

• Treat blood clots that are in your blood.
• Stop blood clots from forming in your blood in the following situations:

o Before and after an operation

o When you have an acute illness and face period of limited mobility

o When you have unstable angina (a condition when not enough blood gets to your heart)

o After a heart attack

• Stop blood clots forming in the tubes of your dialysis machine (used for people with severe kidney problems).

2. what you need to know before you use crusia

Do not use Crusia

• If you are allergic to enoxaparin sodium or any of the other ingredients of this medicine (listed in section 6). Signs ofan allergic reaction include: rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.
• If you are allergic to heparin or other low molecular weight heparins such as nadroparin, tinzaparin or dalteparin.
• If you have had a reaction to heparin that caused a severe drop in the number of your clotting cells (platelets) – this reaction is called heparin-induced thrombocytopenia – within the last 100 days or if you have antibodies against enoxaparin in your blood.
• If you are bleeding heavily or have a condition with a high risk of bleeding (such as stomach ulcer, recent surgery of the brain or eyes), including recent bleeding stroke.
• If you are using Crusia to treat blood clots in your body and going to receive spinal or epidural anaesthesia or lumbar puncture within 24 hours.

Warnings and precautions

Crusia should not be used interchangeably with other medicines belonging to the group of low molecular weight heparins. This is because they are not exactly the same and do not have the same activity and instructions for use.

Talk to your doctor or pharmacist before using Crusia if:

• you have ever had a reaction to heparin that caused a severe drop in the number of your platelets
• you are going to receive spinal or epidural anesthesia or lumbar puncture (see Operations and Anaesthetics): a delay should be respected between Crusia use and this procedure
• you have had a heart valve fitted
• you have endocarditis (an infection of the inner lining of the heart)
• you have history of gastric ulcer
• you have had a recent stroke
• you have high blood pressure
• you have diabetes or problems with blood vessels in the eye caused by diabetes (called diabetic retinopathy)
• you have had an operation recently on your eyes or brain
• you are elderly (over 65 years old) and especially if you are over 75 years old
• you have kidney problems
• you have liver problems
• you are underweight or overweight
• you have high level of potassium in your blood (this may be checked with a blood test)
• are currently using medicines which affect bleeding (see section below – Other medicines)

You may have a blood test before you start using this medicine and at intervals while you are using it; this is to check the level of the clotting cells (platelets) and potassium in your blood.

Other medicines and Crusia

Tell your doctor or pharmacist if you are taking or might take/use any other medicines.

• Warfarin – used for thinning the blood
• Aspirin (also known as acetylsalicylic acid or ASA), clopidogrel or other medicines used to stop blood clots from forming (see also in section 3, “Changing of anticoagulant medicine”)
• Dextran injection – used as a blood replacer
• Ibuprofen, diclofenac, ketorolac or other medicines known as non-steroidal anti-inflammatory agents which are used to treat pain and swelling in arthritis and other conditions
• Prednisolone, dexamethasone or other medicines used to treat asthma, rheumatoid arthritis and other conditions
• Medicines which increase potassium level in your blood such as potassium salts, water pills, some medicines for heart problems.

Operations and Anaesthetics

If you are going to have a spinal puncture or an operation where an epidural or spinal anaesthetic is used, tell you doctor that you are using Crusia. See “Do not use Crusia”. Also, tell your doctor if you have any problem with your spine or if you ever had spinal surgery.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

If you are pregnant and have a mechanical heart valve, you may be at an increased risk of developing blood clots. Your doctor should discuss this with you.

If you are breast-feeding or plan to breast-feed, you should ask your doctor for advice before taking this medicine.

Driving and using machines

Crusia does not affect the ability to drive and operate machinery.

It is advised that the trade name and batch number of the product you are using are recorded by your healthcare professional.

3. how to use crusia

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Having this medicine

• Your doctor or nurse will normally give you Crusia. This is because it needs to be given as an injection.
• When you go home, you may need to continue to use Crusia and give it yourself (see instructions below on how to do this).
• Crusia is usually given by injection underneath the skin (subcutaneous).
• Crusia can be given by injection into your vein (intravenous) after certain types of heart attack or operation.
• Crusia can be added to the tube leaving the body (arterial line) at the start of the dialysis session.

Do not inject Crusia into a muscle.

How much will be given to you

• Your doctor will decide how much Crusia to give you. The amount will depend on the reason it is being used.
• If you have problems with your kidneys you may be given a smaller amount of Crusia.

• 1. Treating blood clots that are in your blood

• The usual dose is 150 IU (1.5 mg) for every kilogram of your weight each day or 100 IU/mg (1 mg) for every kilogram of your weight twice a day.
• Your doctor will decide how long you should receive Crusia.

• 2. Stopping blood clots forming in your blood in the following situations:

• ❖ Operation or periods of limited mobility due to an illness

• The dose will depend on how likely you are to develop a clot. You will be given 2,000 IU (20 mg) or 4,000 IU (40 mg) of Crusia each day.
• If you are going to have an operation your first injection will be usually given 2 hours or 12 hours before your operation.
• If you have restricted mobility due to illness, you will normally be given 4,000 IU (40 mg) of Crusia each day.
• Your doctor will decide how long you should receive Crusia.

• ❖ After you have had a heart attack

Crusia can be used for two different types of heart attack called STEMI (ST segment elevation myocardial infarction) or Non STEMI (NSTEMI). The amount of Crusia given to you will depend on your age and the kind of heart attack you have had.

NSTEMI type of heart attack:

• The usual dose is 100 IU (1 mg) for every kilogram of weight every 12 hours.
• Your doctor will normally ask you to take aspirin (acetylsalicylic acid) as well.
• Your doctor will decide how long you should receive Crusia.

STEMI type of heart attack if you are under 75 years old:

• An initial dose of 3,000 IU (30 mg) of Crusia will be given as injection into your vein.
• At the same time you will also be given Crusia as an injection underneath your skin (subcutaneous injection). The usual dose is 100 IU (1 mg) for every kilogram of your weight, every 12 hours.
• Your doctor will normally ask you to take aspirin (acetylsalicylic acid) as well.
• Your doctor will decide how long you should receive Crusia.

STEMI type of heart attack if you are 75 years old or older:

• The usual dose is 75 IU (0.75 mg) for every kilogram of your weight, every 12 hours.
• The maximum amount of Crusia given for the first two injections is 7,500 IU (75 mg).
• Your doctor will decide how long you should receive Crusia.

For patients have an operation called percutaneous coronary intervention (PCI):

Depending on when you were last given Crusia, your doctor may decide to give an additional dose of Crusia before a PCI operation. This is by injection into your vein.

• 3. Stopping blood clots from forming in the tubes of your dialysis machine

• The usual dose is 100 IU (1 mg) for every kilogram of your weight.
• Crusia is added to the tube leaving the body (arterial line) at the start of the dialysis session. This amount is usually enough for a 4-hour session. However, your doctor may give you a futher dose of50 IU to 100 IU (0.5 to 1 mg) for every kilogram of your weight, if necessary.

Instructions for use of the syringe

If you are able to give Crusia to yourself, your doctor or nurse will show you how to do this. Do not try to inject yourself if you have not been trained how to do so. If you are not sure what to do, talk to your doctor or nurse immediately.

You should follow these steps:

• – Wash your hands well and sit or lie in a comfortable position.

• – Choose an area of the waist, at least 5 centimetres away from your belly button and from existing scars or bruises and clean the skin carefully.

• – Use different places for the injection on different days, for example, first on the left hand side, next time on the right.

• – Pull the needle cap off the syringe.

• – To keep the needle sterile, make sure it doesn’t touch anything.

• – This pre-filled syringe is now ready for use.

• – Before injecting, do not push the plunger to get rid of any air bubbles, because you might lose the medicine.

Hold the syringe in one hand and with your other hand, using your forefinger and thumb, gently pinch the area of skin which you’ve cleaned and make a skin fold.

Insert the full length of the needle into the folded skin, straight in at a 90° angle.

Press down on the plunger, making sure you hold the skin fold in position throughout the injection.

• – Remove the needle by pulling it straight out and let go of the skin fold.

• – Don’t rub the skin where you put the needle in. This will help to avoid bruises.

• – Don’t try to put the needle cap back on the syringe. Just drop it (needle first) into a sharps bin, close the container lid tightly and place it out of reach of children.

• – If you get the impression that the dose is either too strong (for example, you are experiencing unexpected bleeding) or too weak (for example, the dose doesn’t seem to be working), talk to your doctor or pharmacist.

To avoid bruising, do not rub the injection site after you have injected yourself.

Changing of anticoagulant treatment

• - Changing from Crusia to blood thinners called vitamin-K antagonists (e.g. warfarin)

Your doctor will request you perform blood tests called INR and tell you when to stop Crusia accordingly.

• - Changing from blood thinners called vitamin-K antagonists (e.g. warfarin) to Crusia

Stop taking the vitamin-K antagonist. Your doctor will request you perform blood tests called INR and tell you when to start Crusia accordingly.

• - Changing from Crusia to treatment with direct oral anticoagulant

Stop taking Crusia. Start taking the direct oral anticoagulant 0–2 hours before the time you would have had the next injection, then continue as normal.

• - Changing from treatment with direct oral anticoagulant to Crusia

Stop taking direct oral anticoagulant. Do not start treatment with Crusia until 12 hours after the final dose of direct oral anticoagulant.

Use in children and adolescents

The safety and efficacy of Crusia has not been evaluated in children or adolescents.

If you use more Crusia than you should

If you think that you have used too much or too little Crusia, tell your doctor, nurse or pharmacist immediately, even if you have no signs ofa problem. Ifa child accidentally injects or swallows Crusia, take them to a hospital causualty department straight away.

If you forget to use Crusia

If you forget to give yourself a dose, have it as soon as you remember. Do not give yourself a double dose on the same day to make up for a forgotten dose. Keeping a diary will help to make sure you do not miss a dose.

If you stop using Crusia

If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.

It is important for you to keep having Crusia injections until your doctor decides to stop them. If you stop, you could get a blood clot which can be very dangerous.

4. possible side effects

Like other similar medicines (medicines to reduce blood clotting), Crusia may cause bleeding which may potentially be life-threatening. In some cases the bleeding may not be obvious.

If you experience any bleeding event that does not stop by itself or if you experience signs of excessive bleeding (exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling), consult your doctor immediately.

Your doctor may decide to keep you under closer observation or change your medicine.

Stop using Crusia and talk to a doctor or nurse at once if you get any signs of a severe allergic reaction (such as difficulty breathing, swelling of the lips, mouth, throat or eyes).

You should tell your doctor straight away

• If you have any sign of blockage of a blood vessel by a blood clot such as:

• – cramping pain, redness, warmth, or swelling in one of your legs – these are symptoms of deep vein thrombosis

• – breathlessness, chest pain, fainting or coughing up blood – these are symptoms ofa pulmonary embolism

• If you have a painful rash of dark red spots under the skin which do not go away when you put pressure on them.

Your doctor may request you perform a blood test to check your platelet count.

Overall list of possible side effects:

Very common (may affect more than 1 in 10 people)

• Bleeding.
• Increases in liver enzymes.

Common (may affect up to 1 in 10 people)

• You bruise more easily than usual. This could be because ofa blood problem with low platelet counts.
• Pink patches on your skin. These are more likely to appear in the area you have been injected with Crusia.
• Skin rash (hives, urticaria).
• Itchy red skin.
• Bruising or pain at the injection site.
• Decreased red blood cell count.
• High platelet counts in the blood.
• Headache.

Uncommon (may affect up to 1 in 100 people)

• Sudden severe headache. This could be a sign of bleeding in the brain.
• A feeling of tenderness and swelling in your stomach. You may have bleeding in your stomach.
• Large red irregularly shaped skin lesions with or without blisters.
• Skin irritation (local irritation).
• You notice yellowing of your skin or eyes and your urine becomes darker in colour. This could be a liver problem.

Rare (may affect up to 1 in 1,000 people)

• Severe allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.
• Increased potassium in your blood. This is more likely to happen in people with kidney problems or diabetes. Your doctor will be able to check this by carrying out a blood test.
• An increase in the number of eosinophils in your blood. Your doctor will be able to check this by carrying out a blood test.
• Hair loss.
• Osteoporosis (a condition where your bones are more likely to break) after long term use.
• Tingling, numbness and muscular weakness (particularly in the lower part of your body) when you have had a spinal puncture or a spinal anaesthetic.
• Lost of control over your bladder or bowel (so you cannot control when you go to the toilet).
• Hard mass or lump at the injection site.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V *. By reporting side effects you can help provide more information on the safety of this medicine.

5. how to store crusia

Store below 25°C. Do not freeze.

Crusia prefilled syringes are single dose containers – discard any unused product.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month.

Do not use this medicine if you notice the syringe is damaged or the product is not clear.

Medicines should not be disposed via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. contents of the pack and other information- the active substance is enoxaparin sodium.

Each pre-filled syringe contains enoxaparin sodium 2,000 IU anti-Xa activity (equivalent to 20 mg) in 0.2 mL water for injections.

Each pre-filled syringe contains enoxaparin sodium 4,000 IU anti-Xa activity (equivalent to 40 mg) in 0.4 mL water for injections.

Each pre-filled syringe contains enoxaparin sodium 6,000 IU anti-Xa activity (equivalent to 60 mg) in 0.6 mL water for injections.

Each pre-filled syringe contains enoxaparin sodium 8,000 IU anti-Xa activity (equivalent to 80 mg) in 0.8 mL water for injections.

Each pre-filled syringe contains enoxaparin sodium 10,000 IU anti-Xa activity (equivalent to 100 mg) in 1 mL water for injections.

The other ingredient is water for injections.

What Crusia looks like and contents of the pack

Crusia is a clear, colurless to pale yelow solution for injection in a Type I glass pre-filled syringe fitted with an injection needle and with or without an automatic safety device. It is supplied as follows:

Crusia 2,000 IU (20 mg)/0.2mL solution for injection in a 0.5 mL pre-filled syringe without scale. Packs of 2, 6, 10, 20 and 50 syringes.

Crusia 4,000 IU (40 mg)/0.4mL solution for injection in a 0.5 mL pre-filled syringe without scale.

Packs of 2, 6, 10, 20, 30 and 50 syringes.

Crusia 6,000 IU (60 mg)/0.6mL solution for injection in a 1mL graduated pre-filled syringe.

Packs of 2, 6, 10, 12, 24 and 30 syringes.

Crusia 8,000 IU (80 mg)/0.8mL solution for injection in a 1mL graduated pre-filled syringe.

Packs of 2, 6, 10, 12, 24 and 30 syringes.

Crusia 10,000 IU (100 mg)/1mL solution for injection in a 1mL graduated pre-filled syringe.

Packs of 2, 6, 10, 12, 24 and 30 syringes.

Not all pack sizes may be marketed.

In some package sizes, the prefilled syringe may be combined to a safety device system.

For syringes with safety device system the needle must be oriented away from the user and anyone else who is present. The safety system is activated by pressing firmly on the plunger rod. The protective sleeve will automatically cover the needle and will produce an audible click which confirms the activation of the device.

Immediately, the syringe must be discarded by throwing it into the nearest sharps bin (the needle in). The container lid must be closed tightly and the container placed out of the reach of children.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Laboratorios Farmaceuticos ROVI, S.A.

Julian Camarillo, 35

28037 – Madrid Spain

Manufacturer

ROVI CONTRACT MANUFACTURING, S.L.

Julian Camarillo, 35

28037 – Madrid Spain

This medicinal product is authorised in the Member States of the EEA under the following names:

This leaflet was last revised in <{month YYYY}>.

Other sources of information

Detailed information on this medicine is available on the website of {name of MS Agency (link)}

9